YK

Yogita Keshav Velankar

Director Director DIN 05323245
DIN 05323245 First appointment Sep 2012 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Past companies 2 historical roles
Total affiliations 2 Since Sep 2012
Shareholding value •••• Premium profile

About Yogita Keshav Velankar

Data last updated:

Yogita Keshav Velankar was a Director at Stemplus Biotech Private Limited (2012–2013) and Director at Stemplus Cryo Preservation Private Limited (2012–2013). The companies operate in Healthcare.

DIN 05323245
Primary Designation Director
Industry Healthcare
First Appointment 11 Sep 2012

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Stemplus Biotech Private Limited U73100PN2012PTC144685
Director11 Sep 20122012₹5,401 (FY 2025)Active
Director11 Sep 20122012₹13.3 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Stemplus Biotech Private Limited
Stemplus Cryo Preservation Private Limited
Premium access

Shareholding and investment profile for Yogita Keshav Velankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Yogita Keshav Velankar

Yogita Keshav Velankar was first appointed on 11 Sep 2012 as Director at Stemplus Biotech Private Limited.

Yogita Keshav Velankar held 2 earlier board appointments: Stemplus Biotech Private Limited (Director, 11 Sep 2012 to 07 Feb 2013); Stemplus Cryo Preservation Private Limited (Director, 11 Sep 2012 to 07 Feb 2013).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available